Quell Therapeutics at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
Quell Therapeutics takes part in 3 sessions at Cell 2026 in London, its home city. Its sessions centre on quality control and assays for cell therapies, and on linking upstream and downstream processing. A distinctive topic is lessons from moving assays between teams and sites so they scale.
| Organization | Cell 2026 Attendance |
|---|---|
Quell Therapeutics London, UK | |
Develops engineered regulatory T-cell therapies for immune-mediated diseases and transplant rejection. | Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs Cell and gene therapyAnalytics and characterization Talk Thu Nov 12 5:20pm–5:45pm Lessons Learned From Cross-Team & Multi-Site Collaboration To Improve Assay Transfer & Scalability Analytics and characterization Panel Fri Nov 13 1:55pm–2:20pm Closing The Gap: Connecting Upstream And Downstream Bioprocessing In Cell-Based Therapies Cell culture and upstream processingCell and gene therapy |
Instantly find 20 buyers from Quell Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction